QIAGEN Gets FDA Clearance for Outpatient Respiratory Treatment Test
QIAGEN’s QIAstat-Dx Respiratory Panel Mini provides fast and accurate diagnosis of upper respiratory infections in outpatient settings.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Flu & Respiratory Infections |
QIAGEN’s QIAstat-Dx Respiratory Panel Mini provides fast and accurate diagnosis of upper respiratory infections in outpatient settings.
Read MorePosted by Chris Wolski | Nov 1, 2024 | Sepsis |
VolitionRx’s report demonstrated that the Nu.Q NETs sepsis test can predict patients who are at higher risk of deteriorating from sepsis.
Read MorePosted by Chris Wolski | Oct 30, 2024 | Immunoassay |
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Chris Wolski | Oct 29, 2024 | Unknown Origin & Other Cancer Types |
Previse presented clinical utility data for their epigenetic test Esopredict, which aids in optimizing care for Barrett’s esophagus patients.
Read MorePosted by Andy Lundin | Oct 25, 2024 | Cardiovascular, Prenatal Testing |
The biomarker could enable prenatal detection of single ventricle heart disease through a maternal blood test for earlier diagnosis.
Read More